Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Madrigal Pharmaceuticals (MDGL) Other Non-Current Liabilities: 2009-2011

Historic Other Non-Current Liabilities for Madrigal Pharmaceuticals (MDGL) over the last 2 years, with Mar 2011 value amounting to $12.5 million.

  • Madrigal Pharmaceuticals' Other Non-Current Liabilities rose 104.56% to $12.5 million in Q1 2011 from the same period last year, while for Mar 2011 it was $12.5 million, marking a year-over-year increase of 104.56%. This contributed to the annual value of $13.9 million for FY2010, which is 83.96% up from last year.
  • Latest data reveals that Madrigal Pharmaceuticals reported Other Non-Current Liabilities of $12.5 million as of Q1 2011, which was down 9.68% from $13.9 million recorded in Q4 2010.
  • In the past 5 years, Madrigal Pharmaceuticals' Other Non-Current Liabilities registered a high of $129.9 million during Q1 2009, and its lowest value of $4.8 million during Q2 2010.
  • Over the past 3 years, Madrigal Pharmaceuticals' median Other Non-Current Liabilities value was $10.4 million (recorded in 2009), while the average stood at $23.4 million.
  • Its Other Non-Current Liabilities has fluctuated over the past 5 years, first plummeted by 95.29% in 2010, then surged by 104.56% in 2011.
  • Madrigal Pharmaceuticals' Other Non-Current Liabilities (Quarterly) stood at $7.5 million in 2009, then skyrocketed by 83.96% to $13.9 million in 2010, then spiked by 104.56% to $12.5 million in 2011.
  • Its Other Non-Current Liabilities was $12.5 million in Q1 2011, compared to $13.9 million in Q4 2010 and $16.7 million in Q3 2010.